Yes! Merck is supposedly conducting a trial on a therapeutic as we speak! You know the one called molnupiravir. This little project set our fed govt back 1.7 B to develop.
Funny, their course of treatment for this experimental therapy is every 12 hours for 5 days. The duration of administration for their research protocol is somewhat similar to what the good clinicians at FLCCC.net are recommending for Ivermectin for the early outpatient protocol.
RE: Merck is supposedly conducting a trial on a therapeutic as we speak! You know the one called molnupiravir.
The irony is Merck was the original manufacturer of Ivermectin, the patent license of which expired decades ago. It’s no surprise that Merck does not encourage the use of Ivermectin for Covid.
Some people actually suspect that Molnupiravir is an updated version of Ivermectin ( don’t quote me, I’m just presenting what I’ve read ).